The nuclear factor-κB/inhibitor of kappa B autoregulatory system and atherosclerosis

Current Opinion in Lipidology

Volumn 9, Issue 5, 1998, Pages 387-396

  Thurberg, Beth L ^a   Collins, Tucker ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; PHOSPHOTRANSFERASE; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR RECEPTOR;

ATHEROGENESIS; ATHEROSCLEROSIS; AUTOREGULATION; CELL DEATH; DEGRADATION; ENZYME ACTIVATION; FORCE; GENE EXPRESSION; OXIDATION; PHOSPHORYLATION; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SURVIVAL;

ARTERIOSCLEROSIS; CELL ADHESION MOLECULES; CELL DEATH; CYTOKINES; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION; NF-KAPPA B; RECEPTORS, TUMOR NECROSIS FACTOR; SIGNAL TRANSDUCTION;

EID: 0031758996     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041433-199810000-00002     Document Type: Review

References (102)

1. Cybulsky M, Gimbrone M. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science 1991; 251:788-791.
2. Poston RN, Haskard DO, Coucher JR, Gall NP, Johnson-Tidey RR. Expression of intercellular adhesion molecule-1 in atherosclerotic plaques. Am J Pathol 1992; 140:665-673.
3. Cushing SD, Berliner JA, Valente AJ, Territo MC, Navab M, Parhami F, et al. Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. Proc Natl Acad Sci U S A 1990; 87:5134-5138.
4. Clinton SK, Underwood R, Hayes L, Sherman ML, Kufe DW, Libby P. Macrophage colony stimulating factor gene expression in vascular cells and in experimental and human atherosclerosis. Am J Pathol 1992; 140:301-316.
5. Liao F, Andalibi A, Qiao J-H, Allayee H, Fogelman AM, Lusis AJ. Genetic evidence for a common pathway mediating oxidative stress, inflammatory gene induction, and aortic fatty streak formation in mice. J Clin Invest 1994; 94:877-884.
6. Erl W, Weber C, Wardemann C, Weber PC. α-Tocopheryl succinate inhibits monocyte cell adhesion to endothelial cells by suppressing NF-κB mobilization. Am J Physiol 1997; 273:H634-H640.
7. Carew TE, Shurenke DC, Steinberg D. Antiatherogenic effect of probucol unrelated to its hypercholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit LDL degradation in macrophage rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit. Proc Natl Acad Sci USA 1987; 84:7725-7729.
8. Collins T. Endothelial nuclear factor KB and the initiation of the atherosclerotic lesion. Lab Invest 1993; 68:499-508.
9. Brand K, Page S, Rogler G, Bartsch A, Brandi R, Knuechel R, et al. Activated transcription factor NF-κB is present in the atherosclerotic lesion. J Clin Invest 1996; 97:1715-1722.
10. Beg AA, Baldwin AS. The IκB proteins: multifunctional regulators of Rel/NF-κB transcription factors. Genes Dev 1993; 7:2064-2070.
11. Verma IM, Stevenson JK, Schwarz EM, Van Antwerp D, Miyamoto S. Rel/NF-κB/IκB family: intimate tales of association and dissociation. Genes Dev 1995; 9:2723-2735.
12. Baldwin AS. The NF-κB and IκB-α proteins: new discoveries and insights. Ann Rev Immunol 1996; 14:649-681.
13. Finco TS, Beg AA, Baldwin AS. Inducible phosphorylation of IκB-α is not sufficient for its dissociation from NF-κB and is inhibited by protease inhibitors. Proc Natl Acad Sci U S A 1994; 91:11884-11888.
14. Brockman JA, Scherer DC, McKinsey TA, Hall SM, Qi X, Lee WY, Ballard DW. Coupling of a signal response domain in IκB-α to multiple pathways for NF-κB activation. Mol Cell Biol 1995; 15:2809-2818.
15. Chen Z, Hagler J, Palombella VJ, Melandri F, Scherer D, Ballard D, Maniatis T. Signal-induced site-specific phosphorylation targets IκB-α to the ubiquitin-proteosome pathway. Genes Dev 1995; 9:1586-1597.
16. Ciechanover A. The ubiquitin-proteosome proteolytic pathway. Cell 1994; 79:13-21.
17. Brown K, Gerstberger S, Carlson L, Franzoso G, Siebenlist U. Control of IκB-α proteolysis by site-specific, signal-induced phosphorylation. Science 1995; 267:1485-1488.
18. Brockman JA, Scherer DC, McKinsey TA, Hall SM, Qi X, Lee WY, Ballard DW. Coupling of a signal response domain in IκB-α to multiple pathways for NF-κB activation. Mol Cell Biol 1995; 15:2809-2818.
19. Imbert V, Rupee RA, Livolsi A, Pahl HL, Traenckner EB, Muller-Dieckmann C, et al. Tyrosine phosphorylation of IκB-α activates NF-κB without proteolytic degradation of IκB-α. Cell 1996; 86:787-798.
20. Schulze-Osthoff K, Bauer MKA, Vogt M, Wesselborg S. Oxidative stress and signal transduction. Int J Vitamin Nutr Res 1997; 67:336-342.
21. Piette J, Piret B, Bonizzi G, Schoonbroodt S, Merville M-P, Legrand-Poels S, Bours V. Multiple redox regulation in NF-κB transcription factor activation. Biol Chem 1997; 378:1237-1245.
22. Brand K, Page S, Walli AK, Neumeier D, Baeuerle PA. Impaired endothelial function and smooth muscle cell function in oxidative stress: role of nuclear factor-κB in atherogenesis. Exp Physiol 1997; 82:297-304.
23. Griendling KK, Alexander RW. Oxidative stress and cardiovascular disease. Circulation 1997; 96:3264-3265.
24. Kopp E, Ghosh S. Inhibition of NF-κB by sodium salicylate and aspirin. Science 1994; 265:956-959.
25. Maniatis T. Catalysis by a multiprotein IκB kinase complex. Science 1997; 278:818-819. This is a concise review of the TNFR signaling cascade leading to NF-κB activation.
26. Hsu H, Xiong J, Goeddel DV. The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation. Cell 1995; 81:495-504.
27. Stanger BZ, Leder P, Lee T-H, Kim E, Seed B. RIP: a novel protein containing a death domain that interacts with fas/apo-1 (cd95) in yeast and causes cell death. Cell 1995; 81:513-523.
28. Malinin NL, Boldin MP, Kovalenko AV, Wallach D. MAP3K-related kinase involved in NF-κB induction by TNF, CD95 and IL-1. Nature 1997; 385:540-544. An identification of the NIK kinase is described.
29. Lee SY, Reichlin A, Santana A, Sokol KA, Nussenzweig MC, Choi Y. TRAF2 is essential for JNK but not NF-κB activation and regulates lymphocyte proliferation and survival. Immunity 1997; 7:703-713.
30. Song HY, Regnier CH, Kirschning CJ, Goeddel DV, Rothe M. Tumor necrosis factor (TNF)-mediated kinase cascades: bifurcation of nuclear factor-κB and c-jun N-terminal kinase (JNK/SAPK) pathways at TNF receptor-associated factor 2. Proc Natl Acad Sci USA 1997; 94:9792-9796.
31. Verma IM, Stevenson J. IκB kinase: beginning, not the end. Proc Natl Acad Sci USA 1997; 94:11758-11760. A discussion of the recent characterization of the IκB kinase cascade.
32. Stancovski I, Baltimore D. NF-κB activation: the κB kinase revealed? Cell 1997; 91:299-302.
33. Israel A. IκB kinase all zipped up. Nature 1997; 388:519-521.
34. •].
35. •].
36. •].
37. •].
38. •].
39. Chen ZJ, Parent L, Maniatis T. Site-specific phosphorylation of IκB-α by a novel ubiquitination-dependent protein kinase activity. Cell 1996; 84:853-862.
40. Lee FS, Hagler J, Chen ZJ, Maniatis T. Activation of the IκB-α kinase complex by MEKK1, a kinase of the JNK pathway. Cell 1997; 88:213-222.
41. Schulze-Osthoff K, Ferrari D, Reihemann K, Wesselborg S. Regulation of NF-κB activation by Map kinase cascades. Immunobiology 1997; 198:35-49.
42. Zhong H, SuYang H, Erdjument-Bromage H, Tempst P, Ghosh S. The transcriptional activity of NF-κB is regulated by the IκB-associated PKAc subunit through a cyclic AMP-independent mechanism. Cell 1997; 89:413-424.
43. Zhong H, Voll RE, Ghosh S. Phosphorylation of NF-κB p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBPip300. Mol Cell 1998; 1:661-671.
44. Bird TA, Schooley K, Dower SK, Hagen H, Virca GD, Activation of nuclear transcription factor NF-κB by interleukin-1 is accompanied by casein kinase II-mediated phosphorylation of the p65 subunit. J Biol Chem 1997; 272:32606-32612.
45. Berghe WV, Plaisance S, Boone E, De Bosscher K, Schmitz ML, Fiers W, Haegeman G. p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways are required for nuclear factor-κB p65 transactivation mediated by tumor necrosis factor. J Biol Chem 1998; 273:3285-3290.
46. Read MA, Neish AS, Gerritsen ME, Collins T. Postinduction transcriptional repression of E-selectin and vascular cell adhesion molecule-1. J Immunol 1996; 157:3472-3479.
47. Klement JF, Rice NR, Car BD, Abbondanzo SJ, Powers GD, Bhatt H, et al. IκB-α deficiency results in a sustained NF-κB response and severe widespread dermatitis in mice. Mol Cell Biol 1996; 16:2341-2349.
48. Beg AA, Sha WC, Bronson RT, Baltimore D. Constitutive NF-κB activation, enhanced granulopoiesis, and neonatal lethality in IκB-α-deficient mice. Genes Dev 1995; 9:2736-2746.
49. Lindner V, Collins T. Expression of NF-κB and IκB-α by aortic endothelium in an arterial injury model. Am J Pathol 1996; 148:427-438.
50. Chinnaiyan AM, O'Rourke K, Tewari M, Dixit VM. FADD, a novel death domain-containing protein, interacts with the death domain of fas and initiates apoptosis. Cell 1995; 81:505-512.
51. Salvesen GS, Dixit VM. Caspases: intracellular signaling by proteolysis. Cell 1997; 91:443-446.
52. Hsu H, Hong-Bing S, Pan M-G, Goeddel DV. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 1996; 84:299-308.
53. Sonenshein GE. Rel/NF-κB transcription factors and the control of apoptosis. Cancer Biol 1997; 8:113-119.
54. Baichwal VR, Baeuerle PA. Apoptosis: activate NF-κB or die? Curr Biol 19977:R94-R96.
55. Attar RM, Caamano J, Carrasco D, Iotsova V, Ishikawa H, Ryseck R-P, et al. Genetic approaches to study Rel/NF-κB/IκB function in mice. Cancer Biol 1997; 8:93-101. A comprehensive review of transgenic and knockout mice designed to study NF-κB/IκB function, including descriptions of the resulting phenotypes.
56. Kelliher MA, Grimm S, Ishida Y, Kuo F, Stanger BZ, Leder P. The death domain kinase RIP mediates the TNF-induced NF-κB signal. Immunity 1998; 8:297-303. This report suggests that RIP is important in NF-κB signaling induced by TNF.
57. Yeh W-C, Shahinian A, Speiser D, Kraunus J, Billia F, Wakeham A, et al. Early lethality, functional NF-κB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice. Immunity 1997; 7:715-725.
58. Beg AA, Sha WC, Bronson RT, Ghosh S, Baltimore D. Embryonic lethality and liver degeneration in mice lacking the ReIA component of NF-κB. Nature 1995; 376:167-170.
59. Wang CY, Mayo MW, Baldwin AS. TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-κB. Science 1996; 274:784-787.
60. Van Antwerp DJ, Martin SJ, Kafri T, Green DR, Verma IM. Suppression of TNF-alpha-induced apoptosis by NF-κB. Science 1996; 274:787-789.
61. Van Antwerp DJ, Martin SJ, Verma IM, Green DR. Inhibition of TNF-induced apoptosis by NF-κB. Trends Cell Biol 1998; 8:107-110.
62. Ferran C, Stroka DM, Badrichani AZ, Cooper JT, Wrighton CJ, Soares M, et al. A20 inhibits NF-κB activation in endothelial cells without sensitizing to tumor necrosis factor-mediated apoptosis. Blood 1998; 91:2249-2258.
63. 3 integrin-induced endothelial cell survival. J Cell Biol 1998; 18:1083-1093. The authors demonstrate extracellular matrix-induced NF-κB-dependent survival signals.
64. Karsan A, Yee E, Kaushansky K, Harlan JM. Cloning of human Bcl-2 homologue: inflammatory cytokines induce human A1 in cultured endothelial cells. Blood 1996; 87:3089-3096.
65. Karsan A, Yee E, Harlan JM. Endothelial cell death induced by TNF-α is inhibited by the Bcl-2 family member. A1. J Biol Chem 1996; 271:27201-27204.
66. Karsan A, Harlan JM. Modulation of endothelial cell apoptosis: mechanisms and pathophysiological roles. J Atheroscler Thromb 1996; 3:75-80.
67. Karsan A, Yee E, Poirier GG, Zhou P, Craig R, Harlan JM. Fibroblast growth factor-2 inhibits endothelial cell apoptosis by Bcl-2-dependent and independent mechanisms. Am J Pathol 1997; 151:1775-1784.
68. Bach FH, Hancock WW, Ferran C. Protective genes expressed in • endothelial cells: a regulatory response to injury. Immunol Today 1997; 18:483-486. A concise discussion about the role of survival genes in response to endothelial cell injury.
69. Gilmore TD. Clinically relevant findings. J Clin Invest 1997; 100:2935-2936.
70. Wu M, Lee H, Bellas RE, Schauer SL, Arsura M, Katz D, et al. Inhibition of NF-κB/Rel induces apoptosis of murine B cells. EMBO J 1996; 15:4682-4690.
71. LeBoeuf RC, Schreyer SA. The role of tumor necrosis factor-α receptors in atherosclerosis. Trends Cardiovasc Med 1998; 8:131-138. An excellent review on TNFα, its receptors, and their potential roles in atherosclerosis.
72. Schreyer SA, Peschon JJ, LeBoeuf RC. Accelerated atherosclerosis in mice lacking tumor necrosis factor receptor p55. J Biol Chem 1996; 271:26174-26178.
73. Read MA, Neish AS, Luscinskas FW, Palombella VJ, Maniatis T, Collins T. The proteosome pathway is required for cytokine-induced endothelial-leukocyte adhesion molecule expression. Immunity 1995; 2:493-506.
74. Wrighton CJ, Hofer-Warbinek H, Moll T, Eytner H, Bach FH, de Martin R. Inhibition of endothelial cell activation by adenovirus-mediated expression of IκB-α an inhibitor of the transcription factor NF-κB. J Exp Med 1996; 183:1013-1022.
75. Anrather J, Csizmadia V, Brostjan C, Soares MP, Bach FH, Winkler H. Inhibition of bovine endothelial cell activation in vitro by regulated expression of a transdominant inhibitor of NF-κB. J Clin Invest 1997; 99:763-772.
76. Bach FH, Ferran C, Hechenleitner P, Mark W, Koyamada N, Miyatake T, et al. Accommodation of vascularized xenografts: expression of "protective genes" by donor endothelial cells in a host Th2 cytokine environment. Nat Med 1997; 3:196-204.
77. Cooper JT, Stroka DM, Brostjan C, Palmetshofer A, Bach FH, Ferran C. A20 blocks endothelial cell activation through a NF-κB-dependent mechanism. J Biol Chem 1996; 271:18068-18073.
78. Read MA, Whitley MZ, Williams AJ, Collins T. NF-κB and IκB-α: an inducible regulatory system in endothelial activation. J Exp Med 1994; 179:503-512.
79. Anderson TJ, Gerhard MD, Meredith IT, Charbonneau F, Delagrange D, Creager MA, et al. Systemic nature of endothelial dysfunction in atherosclerosis. Am J Cardiol 1995; 75:71B-74B.
80. Sugiyama S, Kugiyama K, Ogata N, Doi H, Ota Y, Ohgushi M. et al. Biphasic regulation of transcription factor nuclear factor-κB activity in human endothelial cells by lysophosphatidylcholine through protein kinase C-mediated pathway. Arterioscler Thromb Vasc Biol 1998; 18:568-576.
81. Calara F, Dimayuga P, Niemann A, Thyberg J, Diczfalusy U, Witztum JL, et al. Regnstrom: an animal model to study local oxidation of LDL and its biological effects in the arterial wall. Arterioscler Thromb Vasc Biol 1998; 18:884-893.
82. Topper JN, Cai J, Falb D, Gimbrone MA. Identification of vascular endothelial genes differentially responsive to fluid mechanical stimuli: cyclooxygenase-2. manganese Superoxide dismutase, and endothelial cell nitric oxide synthase are selectively up-regulated by steady laminar shear stress. Proc Natl Acad Sci U S A 1996; 93:10417-10422.
83. Resnick N, Gimbrone MA Jr. Hemodynamic forces are complex regulators of endothelial gene expression. FASEB J 1995; 9:874-882.
84. Khachigian LM, Resnick N, Gimbrone MA, Collins T. Nuclear factor-κB interacts functionally with the platelet-derived growth factor B-chain shear-stress response element in vascular endothelial cells exposed to fluid shear stress. J Clin Invest 1995; 96:1169-1175.
85. Jones PL, Ping D, Boss JM. TNF-α and IL-1β regulate the murine manganese Superoxide dismutase gene through a complex intronic enhancer involving C/EBP-β and NF-κB. Mol Cell Biol 1997; 17:6970-6981.
86. Crofford LJ, Tan B, McCarthy CJ, Hla T. Involvement of NF-κB in the regulation of cyclooxygenase expression by interleukin-1 in rheumatoid synoviocytes. Arthritis Rheum 1997; 40:226-236.
87. Inoue H, Tanabe T. Transcriptional role of the NF-κB site in the induction by lipopolysaccharide and suppression by dexamethasone of cyclooxygenase-2 in U937 cells. Biochem Biophys Res Commun 1998; 244:143-148.
88. Schmedtje JF Jr, Ji YS, Liu WL, DuBois RN, Runge MS. Hypoxia induces cyclooxygenase-2 via the NF-κB p65 transcription factor in human vascular endothelial cells. J Biol Chem 1997; 272:601-608.
89. Hsu H-Y, Nicholson AC, Hajjar DP. Inhibition of macrophage scavenger receptor activity by tumor necrosis factor-α is transcriptionally and post-transcriptionally regulated. J Biol Chem 1996; 271:7767-7773.
90. Hernandez-Presa M, Bustos C, Ortego BS, Tunon J, Renedo G, Ruiz-Ortega M, Egido J. Angiotensin-converting enzyme inhibition prevents arterial nuclear factor-κB activation, monocyte chemoattractant protein-1 expression, and macrophage infiltration in a rabbit model of early accelerated atherosclerosis. Circulation 1997; 95:1532-1541.
91. Ruiz-Ortega M, Bustos C, Hernandez-Presa MA, Lorenzo O, Plaza JJ, Egido J. Angiotensin II participates in mononuclear cell recruitment in experimental immune complex nephritis through nuclear factor-κB activation and monocyte chemoattractant protein-1 synthesis. J Immunol 1998; 161:430-439.
92. Shackelford RE, Alford PB, Xue Y, Thai SF, Adams DO, Pizzo S. Aspirin inhibits TNFα gene expression in murine tissue macrophages. Mol Pharmacol 1997; 52:421-429.
93. Velasco M, Diaz-Guerra MJ, Martin-Sanz P, Alvarez A, Bosca L. Rapid up-regulation of IκB-β and abrogation of NF-κB activity in peritoneal macrophages stimulated with lipopolysaccharide. J Biol Chem 1997; 272:23025-23030.
94. Hwang D, Jang BC, Yu G, Boudreau M. Expression of mitogen-inducible cyclooxygenase induced by lipopolysaccharide: mediation through both mitogen-activated protein kinase and NF-κB signaling pathways in macrophages. Biochem Pharmacol 1997; 54:87-96.
95. D'Acquisto F, Iuvone T, Rombola L, Sautebin L, Di Rosa M, Carnuccio R. Involvement of NF-κB in the regulation of cyclooxygenase-2 protein expression in LPS-stimulated J774 macrophages. FEBS Lett 1997; 418:175-178.
96. Brand K, Eisele T, Kreusel U, Page M, Page S, Haas M, et al. Dysregulation of monocytic NF-κB by oxidized low-density lipoprotein. Arterioscler Thromb Vasc Biol 1997; 17:1901-1909.
97. Kaul N, Choi J, Forman HJ. Transmembrane redox signaling activates NF-κB in macrophages. Free Radic Biol Med 1998; 24:202-207.
98. Bourcier T, Sukhova G, Libby P. The nuclear factor κ-B signaling pathway participates in dysregulation of vascular smooth muscle cells in vitro and in human atherosclerosis. J Biol Chem 1997; 272:15817-15824.
99. Ross H. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362:801-809.
100. Cercek B, Yamashita M, Dimayuga P, Zhu J, Fishbein MC, Kaul S, et al. Nuclear factor-κB and arterial response to balloon injury. Atherosclerosis 1997; 131:59-66.
101. Landry DB, Couper LL, Bryant SR, Lindner V. Activation of the NF-κB and IκB system in smooth muscle cells after rat arterial injury. Am J Pathol 1997; 151:1085-1095.
102. Pierce JW, Read MA, Ding H, Luscinskas FW, Collins T. Salicylates inhibit IκB-α phosphorylation, endothelial-leukocyte adhesion molecule expression, and neutrophil transmigration. J Immunol 1996; 156:3961-3969.